Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid Leukemia
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 19 (3) , 142-148.e1
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- SymBio Pharmaceuticals Limited
- Teva Pharmaceutical Industries
- Amgen
- Celgene
- Bristol-Myers Squibb
- University of Texas MD Anderson Cancer Center (CA016672)
- Pfizer
- Astellas Pharma Global Development
- Sunesis
- Novartis
- Merck
This publication has 38 references indexed in Scilit:
- Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapyLeukemia, 2011
- Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in Braf-Mutant Human Cutaneous Melanoma CellsCancer Research, 2010
- AML with CBFB–MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletionsLeukemia, 2010
- Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY‐142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell linesInternational Journal of Cancer, 2009
- Response and resistance to MEK inhibition in leukaemias initiated by hyperactive RasNature, 2009
- A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or olderBlood, 2009
- K-ras as a target for cancer therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2005
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958